- Home
- GH
GH
Guardant Health Inc.
as 03-25-2025 3:31pm EST
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | PALO ALTO |
| Market Cap: | N/A | IPO Year: | 2018 |
| Target Price: | $48.40 | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 20 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $15.81 - $50.89 | Next Earning Date: | 05-08-2025 |
| Revenue: | $739,016,000 | Revenue Growth: | 31.04% |
| Revenue Growth (this year): | 19.11% | Revenue Growth (next year): | 21.44% |
Stock Insider Trading Activity of Guardant Health Inc. (GH)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Tariq Musa | GH | Director | Mar 19 '25 | Sell | $43.70 | 116 | $5,069.20 | 3,211 | |
| Kalia Kumud | GH | Chief Information Officer | Mar 15 '25 | Sell | $43.16 | 3,500 | $151,060.35 | 19,720 | |
| Joyce Meghan V. | GH | Director | Mar 3 '25 | Sell | $42.71 | 100 | $4,271.00 | 7,647 | |
| Tariq Musa | GH | Director | Feb 20 '25 | Sell | $48.33 | 116 | $5,606.28 | 3,211 | |
| Tariq Musa | GH | Director | Jan 17 '25 | Sell | $37.58 | 116 | $4,359.28 | 3,211 |
Latest Guardant Health Inc. News
GH Breaking Stock News: Dive into GH Ticker-Specific Updates for Smart Investing
Investor's Business Daily
5 days ago
These Seven Risky Bets Take The Shine Off Gold; One Looks To Extend 46% Gain
StockStory
6 days ago
1 Healthcare Stock on Our Watchlist and 2 to Turn Down
Morningstar Research
15 days ago
Analyst Report: Guardant Health, Inc.
MT Newswires
15 days ago
Update: Guardant Health Shares Soar After Colorectal Cancer Test Granted ADLT Status
MT Newswires
15 days ago
Guardant Health Says Colorectal Cancer Test Granted ADLT Status
Business Wire
15 days ago
Guardant Health Receives ADLT Status From CMS for Shield Blood Test
Morningstar Research
16 days ago
Analyst Report: Guardant Health, Inc.
MT Newswires
20 days ago
Guardant Health Base Business in 'Fundamentally Good Shape,' Morgan Stanley Says
Compare GH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GH Guardant Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.